The 51³Ô¹Ï (ACHA) recently updated its immunization and tuberculosis (TB) guidelines for college and university students, reflecting current public health practices and the evolving needs of campus communities. The new recommendations aim to support institutions in protecting student health through clearer, more comprehensive guidance.

Immunization Recommendations

The updated 51³Ô¹ÏGuidelines: Immunization Recommendations for College Students provides a comprehensive framework for institutional vaccine policies and patient education. Key enhancements in this version include:

  • New strategic guidance and a dedicated section on outbreak prevention and response.
  • A new summary table for vaccine series completion and catch-up and inclusion of Appendix A for easy comprehension of all referenced vaccine-preventable diseases.
  • New appendices covering international travel, vaccine cost conversations, and a sample immunization submission form.
  • An updated, concise appendix with recommendations for health science students.

Tuberculosis Risk Assessment and Management

The latest updates to the 51³Ô¹ÏGuidelines: Tuberculosis Risk Assessment and Management ensure that campus screening protocols remain aligned with current global health data and ACHA’s overarching goal of protecting our 19 million college students. Key updates in this version include:

  • Strategic Alignment: The introduction now explicitly aligns with the 51³Ô¹ÏImmunization Guidelines to provide a unified approach to campus communicable disease prevention.
  • Updated High-Incidence Country List (Appendix 2): Based on epidemiological data, the list of high-incidence countries has been adjusted.
    • Additions: French Polynesia, Latvia, Syrian Arab Republic, and Trinidad and Tobago
    • Removals: Anguilla and Belarus
  • New Clinical Tool (Appendix 5): The inclusion of a customized Inactive TB Infection (LTBI) Risk Assessment Matrix. This tool is specifically tailored to the unique demographics and risk profiles of college student populations.

These updates provide health services with the most current evidence-based framework for effective TB screening and management in the higher education setting.

51³Ô¹Ïalso updated its FAQs on TB Risk Assessment and Management, a companion to the TB Guidelines. The 2026 version of the FAQs includes updated links and updates for accuracy.

Thank you to the members of the 51³Ô¹ÏVaccine-Preventable Diseases Committee and TB Workgroup who provided these updates and revisions.

 

Topic
Immunizations, Infectious Diseases, Policies & Procedures, Public Health

Post Type
News & Announcements

BRP Pharmaceuticals: In-house physician dispensing enables provides and clinics to offer their student patients timely, convenient, and hassle-free alternatives for receiving their medications/vaccines without leaving the campus.